Our academic clinicians bring knowledge of clinical practice into the lab and take laboratory research back into the clinic ...

We pioneered the application of evolutionary biology to cancer and established cancer stem cells as the units of natural selection. In this clip, filmed in 2016, Dr Andrea Sottoriva explains how the ...

State-of-the-art microscopy is a vital tool in understanding the critical mechanisms of cell growth and division. .

The Cancer Epidemiology and Prevention Research Unit (CEPRU) is a joint initiative between The Institute of Cancer Research, ...

We applied the principle of synthetic lethality to discover a novel strategy for cancer treatment for patients with BRCA1 or BRCA2 gene mutations. We demonstrated that drugs called PARP inhibitors ...

We played a major role in characterising the BRAF gene and its role in cancer, increasing our understanding of malignant melanoma. Our work on the gene and the structure of the BRAF protein ...

Ahead of the AACR-San Antonio Breast Cancer Symposium, we caught up with two ICR researchers and their supervisor to find out ...

We will maximise the impact of our research for patients by engaging with industry, funders, donors and the public, building partnerships in the UK and internationally, and influencing the uptake of ...

The Centre for Molecular Pathology is a collaborative initiative between The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research.

Using funding from the National Institute for Health Research (NIHR), The Institute of Cancer Research offers training programmes that support NHS doctors to undertake specialty training to also train ...

At The Institute of Cancer Research, London, we offer clinicians a variety of opportunities – from a taught master's course in Oncology, to fellowships providing protected time for research, and ...